{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:06:03Z","timestamp":1759017963286,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.annder.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T19:52:41Z","timestamp":1536695561000},"page":"671-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dermite liv\u00e9do\u00efde de Nicolau sus-pubienne apr\u00e8s injections sous-cutan\u00e9es d\u2019ac\u00e9tate de glatiram\u00e8re"],"prefix":"10.1016","volume":"145","author":[{"given":"A.","family":"Blind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lenormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lipsker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.04.012_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/135245850000600407","article-title":"Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6\u00a0years","volume":"6","author":"Johnson","year":"2000","journal-title":"Mult Scler"},{"key":"10.1016\/j.annder.2018.04.012_bib0120","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-006-0233-9","article-title":"Necrotising cutaneous lesions as a side effect of glatiramer acetate","volume":"253","author":"Bosca","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.annder.2018.04.012_bib0125","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/cup.12791","article-title":"Nicolau syndrome and localized panniculitis: a report of dual diagnoses with an emphasis on morphea profunda-like changes following injection with glatiramer acetate","volume":"43","author":"Mott","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2018.04.012_bib0130","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1610-0387.2007.06391.x","article-title":"Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate","volume":"5","author":"Harde","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2018.04.012_bib0135","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1346-8138.2010.00864.x","article-title":"Three cases of embolia cutis medicamentosa (Nicolau's syndrome)","volume":"37","author":"Marangi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2018.04.012_bib0140","first-page":"571","article-title":"Livedo-like dermatitis (Nicolau's syndrome) after injection of Copolymer-1 (Glatiramer acetate)","volume":"159","author":"Gaudez","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.annder.2018.04.012_bib0145","first-page":"742","article-title":"Embolia cutis medicamentosa (s\u00edndrome de Nicolau) tras inyecci\u00f3n de acetato de glatir\u00e1mero","volume":"9","author":"Mart\u00ednez-Mor\u00e1n","year":"2011","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.annder.2018.04.012_bib0150","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jaad.2010.09.003","article-title":"Nicolau syndrome following subcutaneous glatiramer-acetate injection","volume":"64","author":"Koller","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.012_bib0155","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1\u00a0reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2018.04.012_bib0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2017.06.006","article-title":"Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients","volume":"181","author":"Spadaro","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.annder.2018.04.012_bib0165","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.msard.2015.06.005","article-title":"GLACIER: an open label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis","volume":"4","author":"Wolinsky","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.annder.2018.04.012_bib0220","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/1352458516664033","article-title":"Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study","volume":"23","author":"Khan","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.annder.2018.04.012_bib0175","first-page":"321","article-title":"Dermite liv\u00e9do\u00efde et gangr\u00e9neuse de la fesse, cons\u00e9cutive aux injections intramusculaires, dans la syphilis. \u00c0 propos d\u2019un cas d\u2019embolie art\u00e9rielle bismuthique","volume":"20","author":"Nicolau","year":"1925","journal-title":"Ann Mal Vener"},{"key":"10.1016\/j.annder.2018.04.012_bib0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01828197","article-title":"Lokales embolisches Bismugenol Exanthem","volume":"147","author":"Freudenthal","year":"1924","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.annder.2018.04.012_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1468-3083.2001.00320.x","article-title":"Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs","volume":"15","author":"Corazza","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.04.012_bib0190","first-page":"57","article-title":"Nicolau Syndrome after intramuscular injection of non-steroidal anti-inflammatory drugs (NSAID)","volume":"15","author":"Dadaci","year":"2015","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.annder.2018.04.012_bib0195","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1752-1947-8-404","article-title":"Nicolau syndrome due to diclofenac sodium (Voltaren\u00ae) injection a case report","volume":"8","author":"Kilic","year":"2014","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.annder.2018.04.012_bib0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0378-6323.125516","article-title":"Nicolau syndrome involving whole ipsilateral limb induced by intramuscular administration of gentamycin","volume":"80","author":"Kim","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2018.04.012_bib0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/RHU.0000000000000146","article-title":"Livedoid dermatitis (Nicolau Syndrome) following intra-articular glucocorticoid injection","volume":"20","author":"McKinney","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.annder.2018.04.012_bib0210","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/1352458507079612","article-title":"Embolia cutis medicamentosa following interferon beta injection","volume":"13","author":"Koontz","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.annder.2018.04.012_bib0215","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.vaccine.2011.10.107","article-title":"Nicolau syndrome may be caused by intravascular vaccine injection","volume":"30","author":"B\u00e9gin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.annder.2018.04.012_bib0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/DAD.0000000000000972","article-title":"Nicolau Syndrome (Embolia Cutis Medicamentosa): a rare and poorly recognized iatrogenic cause of cutaneous thrombotic vasculopathy","volume":"40","author":"Tabor","year":"2018","journal-title":"Am J Dermatopathol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:40Z","timestamp":1758971200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0151963818305064"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermite liv\u00e9do\u00efde de Nicolau sus-pubienne apr\u00e8s injections sous-cutan\u00e9es d\u2019ac\u00e9tate de glatiram\u00e8re","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}